{"title":"阿片受体激动剂和拮抗剂在晚期慢性肾脏疾病和接受肾脏替代治疗患者中的应用","authors":"A. Sołtysik, M. Graczyk, J. Woroń","doi":"10.5603/pmpi.a2022.0019","DOIUrl":null,"url":null,"abstract":"The basic principles of pharmacotherapy and changes in pharmacokinetics of drugs in this patient group are discussed in another article: Sołtysik A, Graczyk M, Woroń J. Use of opioid analgesics in chronic kidney disease. Palliat Med Pract 2022; 16(3): 156–166; DOI:","PeriodicalId":19965,"journal":{"name":"Palliative Medicine in Practice","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The use of opioid receptor agonists and antagonists in the treatment of patients with advanced chronic kidney disease and undergoing renal replacement therapy\",\"authors\":\"A. Sołtysik, M. Graczyk, J. Woroń\",\"doi\":\"10.5603/pmpi.a2022.0019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The basic principles of pharmacotherapy and changes in pharmacokinetics of drugs in this patient group are discussed in another article: Sołtysik A, Graczyk M, Woroń J. Use of opioid analgesics in chronic kidney disease. Palliat Med Pract 2022; 16(3): 156–166; DOI:\",\"PeriodicalId\":19965,\"journal\":{\"name\":\"Palliative Medicine in Practice\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Palliative Medicine in Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5603/pmpi.a2022.0019\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Palliative Medicine in Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5603/pmpi.a2022.0019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
The use of opioid receptor agonists and antagonists in the treatment of patients with advanced chronic kidney disease and undergoing renal replacement therapy
The basic principles of pharmacotherapy and changes in pharmacokinetics of drugs in this patient group are discussed in another article: Sołtysik A, Graczyk M, Woroń J. Use of opioid analgesics in chronic kidney disease. Palliat Med Pract 2022; 16(3): 156–166; DOI:
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
